Skip to content

NL – AstraZeneca v. Sandoz / FASLODEX

01 Aug 2016

Astrazeneca AB v. Sandoz B.V., PI judge of the District Court of The Hague, 27 July 2016, Case No. ECLI:NL:RBDHA:2016:8700

There is too much doubt that Claim 1 of the Patent in suit will be declared invalid in proceedings on the merits due to lack of inventive step. The requested preliminary injunction therefore will be granted.

A copy of the judgment can be read here.